2023 Vizient PSO Topical Safety Webinar Series - Prevention of high harm maternal events
The presenters will share information on the state of the current maternal health morbidity and mortality crisis to highlight the importance of everyone working together to support safer communities and organizations for women giving birth. Presenters share information pertaining to the impact of postpartum hemorrhage on women experiencing an even and will share the importance of predicting and preventing postpartum hemorrhage events from occurring.
- Other Healthcare Professionals
1. Discuss the prevalence of the maternal health crisis in the United States.
2. Describe the impact of postpartum hemorrhage on maternal morbidity and mortality outcomes.
3. Define key components of the postpartum hemorrhage predictive analysis.
4. Describe methods for operationalizing postpartum predictive analytics into clinical care.
Renee Allen, MD, MHSc, FACOG
Principal, Physician Clinical Operations, Vizient, Inc.
Rebecca Kojak, DNP, RN, PHN, NE-BC, LSSBB, GRCP, GRC-A, CPMP, C-DAP
Senior Consultant, Vizient, Inc.
Stefka Fabbri, MD, MPH
Associate Director of Inpatient Services; Director of Patient Safety and Quality Improvement; Associate Professor; Department of Obstetrics and Gynecology
Denver Health, University of Colorado Anschutz Medical Campus
Identification, Mitigation, and Disclosure of Relevant Financial Relationships
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
Absence of Relevant Financial Relationships
- No one in a position to control the content of this educational activity have relevant financial relationships with ineligible companies.
Statement of content validity
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
FDA off-label/unapproved usage
Faculty/Presenters are required to identify any new and evolving topics for which there is a lower/absence of evidence base. This is to ensure that our content does not advocate for, or promote, practices that are not, or not yet adequately based on current science, evidence, and clinical reasoning. Faculty/Presenters are required to disclose any discussion of (1) off-label/unapproved or investigational uses of FDA approved commercial products or devices and/or (2) products or devices not yet approved in the United States.
The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.
- 1.00 ACPE Pharmacist
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 CBRN
- 1.00 General CE – Attendance